BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 7954237)

  • 1. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
    Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
    Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.
    Laccourreye O; Muscatello L; Laccourreye L; Naudo P; Brasnu D; Weinstein G
    Am J Otolaryngol; 1997; 18(6):385-90. PubMed ID: 9395014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
    Singer MI
    Cancer; 1995 Jul; 76(1):149-51. PubMed ID: 8630866
    [No Abstract]   [Full Text] [Related]  

  • 6. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
    Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
    Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy followed by supracricoid partial laryngectomy (SCPL) with cricohyoidoepiglottopexy (CHEP) in T3NO arytenoid fixation-related glottic cancer.
    Luna-Oritz K; Villavicencio-Valencia V; Rodriguez-Falconi A; Alvarez-Avitia M; Granados-Garcia M; Cano-Valdez AM; Peteuil N
    B-ENT; 2016; 12(4):271-277. PubMed ID: 29709130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients.
    Chevalier D; Laccourreye O; Brasnu D; Laccourreye H; Piquet JJ
    Ann Otol Rhinol Laryngol; 1997 May; 106(5):364-9. PubMed ID: 9153099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["Limited" cancers of the glottic stage of the larynx and exclusive chemotherapy--15 years of experience].
    Laccourreye H
    Bull Acad Natl Med; 1997 Apr; 181(4):641-8; discussion 648-9. PubMed ID: 9312344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma.
    Zhang SY; Lu ZM; Chen LS; Luo XN; Ge PJ; Song XH; Chen SH; Wu YL
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1027-34. PubMed ID: 23241822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis.
    Laccourreye O; Diaz EM; Bassot V; Muscatello L; Garcia D; Brasnu D
    Cancer; 1999 Jan; 85(1):40-6. PubMed ID: 9921972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local recurrence after vertical partial laryngectomy, a conservative modality of treatment for patients with Stage I-II squamous cell carcinoma of the glottis.
    Laccourreye O; Gutierrez-Fonseca R; Garcia D; Hans S; Hacquart N; Ménard M; Brasnu D
    Cancer; 1999 Jun; 85(12):2549-56. PubMed ID: 10375101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results.
    Karasalihoglu AR; Yagiz R; Tas A; Uzun C; Adali MK; Koten M
    J Laryngol Otol; 2004 Sep; 118(9):671-5. PubMed ID: 15509363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exclusive chemotherapy in T1-T3N0 cancers of the vocal cord with complete clinical response after neoadjuvant treatment with a cisplatin-fluorouracil combination].
    Laccourreye O; Bassot V; Brasnu D; Jouffre V; Ménard M; Laccourreye H
    Presse Med; 1995 Oct; 24(29):1337-40. PubMed ID: 7494844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas.
    Bron L; Brossard E; Monnier P; Pasche P
    Laryngoscope; 2000 Apr; 110(4):627-34. PubMed ID: 10764009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.